2019
DOI: 10.1007/s00018-019-03144-y
|View full text |Cite
|
Sign up to set email alerts
|

Understanding histone H3 lysine 36 methylation and its deregulation in disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
95
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
2
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 111 publications
(102 citation statements)
references
References 174 publications
1
95
0
1
Order By: Relevance
“…Since we did not knockdown ASH1L at the neuronal progenitor stage our findings do not discount the potential of ASH1L to be involved in cell fate transitions during human corticogenesis. Additionally, we do not discount that additional epigenetic mechanisms could be at play such as the activity of specific histone demethylases that regulate the methylation of lysine 36 (Li et al, 2019a) and could facilitate the activity of the Polycomb complexes.…”
Section: Discussionmentioning
confidence: 92%
See 1 more Smart Citation
“…Since we did not knockdown ASH1L at the neuronal progenitor stage our findings do not discount the potential of ASH1L to be involved in cell fate transitions during human corticogenesis. Additionally, we do not discount that additional epigenetic mechanisms could be at play such as the activity of specific histone demethylases that regulate the methylation of lysine 36 (Li et al, 2019a) and could facilitate the activity of the Polycomb complexes.…”
Section: Discussionmentioning
confidence: 92%
“…The current ENCODE data sets lack analysis of H3K36me2 that is primarily deposited by ASH1L. However, H3K36me2 presence will lead to upregulation of H3K36me3 by SET2 (Li et al, 2019a), and H3K4me3 marks are deposited by the ASH1L interactor -MLL complex (Zhu et al, 2016a). Therefore, both H3K36me3 and H3K4me3 marks are highly correlated with the presence of H3K36me2 (Miao and Natarajan, 2005), and were used as correlative evidence for the presence of H3K36me2 marks.…”
Section: Ash1l Specifically Regulates the Expression Of The Neurotropmentioning
confidence: 99%
“…In addition to the H3G34 mutations, H3K36M mutations, found in over 90% of chondroblastoma cases and in large subgroup of head and neck sarcomas, function as dominant negative regulators to reduce H3K36me2 and H3K36me3 on wild type histone H3 [95][96][97][98]. H3K36M oncohistones reduces H3K36me2 and H3K36me3 genome-wide through the inhibition of at least two histone H3K36 methyltransferases, NSD2 and SETD2 [96][97][98][99]. Knock-in of heterozygous H3.3K36M mutation into chondrocytes reduces the H3K36 methylation and subsequent expression of cancer related genes.…”
Section: H3k36me3 Associated Ddr In Tumorigenesismentioning
confidence: 99%
“…Indeed, H3K27me3 increases in the intergenic regions where the H3K36me2 is decreased in the H3.3K36M mutate cells [97,98]. How this H3K36M mutation controls DNA damage repair is still unknown [94,99]. More efforts should be placed to discover the detailed molecular mechanisms of how oncohistones promote tumorigenesis through DNA damage repair pathways.…”
Section: H3k36me3 Associated Ddr In Tumorigenesismentioning
confidence: 99%
“…The delay in replication may partly explain the profile, although the mechanism remains unknown. Unlike H3K4 methylation, H3K36me2 and H3K36me3 localized broadly to euchromatin and gene body, respectively (Li et al, 2019;Zee et al, 2010b), and the replication timing of chromatin that harbors these modifications may not be as early as that of H3K4-associated chromatin. Since H3K27 is reportedly methylated (H3K27me1) in combination with H3K36 (Zheng et al, 2016), its dynamics may be similar to H3K36 methylation.…”
mentioning
confidence: 99%